Genentech Halts Enrollment In Avastin Early-Stage Colon Cancer Trial
This article was originally published in The Pink Sheet Daily
Executive Summary
The firm reports a higher rate of non-colon cancer related deaths in the AVANT trial for adjuvant use of bevacizumab.